Month: May 2024

REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical company...

CHARLESTOWN, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision...

MENLO PARK, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an...

ENGLEWOOD, Colo., May 2, 2024 /PRNewswire/ -- EchoStar Corporation (NASDAQ: SATS) will host a conference call to discuss its first...

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today...

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the...

First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 millionReaffirmed 2024 expected...

First Quarter 2024 Financial Highlights:LAKE FOREST, Ill., May 02, 2024 (GLOBE NEWSWIRE) -- Pactiv Evergreen Inc. (“Pactiv Evergreen” or the...

IRVINE, CA / ACCESSWIRE / May 2, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024...

SCHAUMBURG, Ill., May 02, 2024 (GLOBE NEWSWIRE) --  Paylocity Holding Corporation (Nasdaq: PCTY), a leading provider of cloud-based HCM and...

Contacts Alan H. Auerbach or Mariann Ohanesian, Puma Biotechnology, Inc., +1 424 248 6500 info@pumabiotechnology.com ir@pumabiotechnology.com David Schull or Olipriya...

Record Q3 Total Revenues and Enterprise Cloud Bookings Announces $250 Million Share Repurchase Program Fiscal 2024 Third Quarter Highlights Total...

First quarter revenue grew 13% year-over-year to $64.8 million First quarter subscription revenue grew 34% year-over-year to $40.0 million Annual...

SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (“Opendoor”) (Nasdaq: OPEN), a leading e-commerce platform for residential...

SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...

Contacts Universal Display: Darice Liu investor@oled.com media@oled.com +1 609-964-5123 Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with...

BELTSVILLE, Md., May 02, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...

VISTA, Calif., May 2, 2024 /PRNewswire/ -- NuZee, Inc. (NASDAQ: NUZE), a leading coffee co-packing and technology company (the "Company"), today announced...

Contacts (Press) Kenya Hayes 1 703 589 7595 kenya.hayes@netapp.com (Investors) Billie Fagenstrom 1 408 822 6428 billie.fagenstrom@netapp.com After market close...

-- Record First Quarter Net Sales Rise 11.8 Percent to $1.90 Billion ---- Net Sales, Adjusted for Adverse Changes in...

Contacts FGS Global Maiden@fgsglobal.com Maiden Holdings, Ltd. ("Maiden") (NASDAQ: MHLD) announced it plans to release its first quarter 2024 financial...

WORCESTER, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical...

Commercial launch of INPEFA® (sotagliflozin) for Heart Failure continues to progressRead more at globenewswire.com

Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment in the second quarter of 2024.Ended the first...

Bexicaserin (LP352) Phase 1b/2a PACIFIC Study positive topline data in participants with Developmental and Epileptic Encephalopathies (DEEs) were reported in...

– Breakthrough Therapy Designation for ziftomenib in NPM1-mutant AML –– Registration-directed trial of ziftomenib in NPM1-mutant AML on track to...

Contacts Kopin Corporation Nic Peterson Director of Business Development for Warfighter Vision NPeterson@Kopin.com Richard Sneider, 508-870-5959 Treasurer and Chief Financial...

- Grew Q1 2024 Revenue 5%, System-wide Sales 9%, and System-wide Comp Sales 3% vs. Q1 2023 - - Opened...

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatment for...

– Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03; Revenue and Non-GAAP Diluted...

BOSTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel...

ENGLEWOOD, Colo., May 02, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today...

Posts strong first quarter revenue and profitability Revenue grew 8% y/y with margin expansion Accelerated level of share repurchases at...

SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on April 30,...

MINNEAPOLIS, May 02, 2024 (GLOBE NEWSWIRE) -- Clearfield, Inc. (NASDAQ: CLFD), a leader in fiber connectivity, reported results for the...

First Quarter Product Revenue Increased 24% from Prior Year Quarter Contacts Jessica Hanover – Vice President, Corporate Affairs Cerus Corporation...

Record first quarter net sales driven by growth across all three lines of business Disciplined execution led to better-than-expected gross...

Contacts Astria Contact: Investor Relations and Media: Elizabeth Higgins investors@astriatx.com Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing...